Survey of treatment practices for immunocompromised patients with COVID-19 in Australasia

被引:5
作者
Moso, Michael A. [1 ,2 ,3 ]
Sasadeusz, Joe [1 ,3 ]
Morrissey, Catherine O. [4 ,5 ]
Bond, Katherine [2 ,6 ]
Guy, Stephen [7 ,8 ]
Slavin, Monica A. [1 ,10 ,11 ]
Dendle, Claire [9 ,12 ,13 ]
机构
[1] Royal Melbourne Hosp, Victorian Infect Dis Serv, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[2] VIDRL Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Infect Dis, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia
[4] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[5] Monash Univ, Melbourne, Vic, Australia
[6] Royal Melbourne Hosp, Dept Microbiol, Melbourne, Vic, Australia
[7] Eastern Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[8] Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[9] Monash Univ, Sch Clin Sci, Melbourne, Australia
[10] Peter MacCallum Canc Ctr, Dept Infect Dis, Melbourne, Vic, Australia
[11] Peter MacCallum Canc Ctr, Natl Ctr Infect Canc, Melbourne, Vic, Australia
[12] Monash Hlth, Monash Infect Dis, Melbourne, Vic, Australia
[13] Monash Med Ctr, Monash Infect Dis, 246 Clayton Rd, Clayton, Vic, Australia
关键词
COVID-19; immunocompromised; survey; antivirals; transplant; malignancy;
D O I
10.1111/imj.16064
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) in immunocompromised patients can lead to severe and prolonged illness. Data are limited with regard to management of COVID-19 in this setting, particularly in persistent or recrudescent infection. The authors conducted an online survey among infectious diseases doctors to determine current approaches to treatment across Australasia. There was marked variability in responses relating to the diagnostic modalities and use of antiviral agents in patients with immunocompromise, highlighting the need for high-quality studies to guide treatment decisions in this group.
引用
收藏
页码:619 / 624
页数:6
相关论文
共 32 条
  • [1] [Anonymous], NZ MED MED DEV SAF
  • [2] Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
    Avanzato, Victoria A.
    Matson, M. Jeremiah
    Seifert, Stephanie N.
    Pryce, Rhys
    Williamson, Brandi N.
    Anzick, Sarah L.
    Barbian, Kent
    Judson, Seth D.
    Fischer, Elizabeth R.
    Martens, Craig
    Bowden, Thomas A.
    de Wit, Emmie
    Riedo, Francis X.
    Munster, Vincent J.
    [J]. CELL, 2020, 183 (07) : 1901 - +
  • [3] Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
    Aydillo, Teresa
    Babady, N. Esther
    Kamboj, Mini
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26) : 2586 - 2588
  • [4] Remdesivir for the Treatment of Covid-19-Final Report
    Beigel, John H.
    Tomashek, Kay M.
    Dodd, Lori E.
    Mehta, Aneesh K.
    Zingman, Barry S.
    Kalil, Andre C.
    Hohmann, Elizabeth
    Chu, Helen Y.
    Luetkemeyer, Annie
    Kline, Susan
    de Castilla, Diego Lopez
    Finberg, Robert W.
    Dierberg, Kerry
    Tapson, Victor
    Hsieh, Lanny
    Patterson, Thomas F.
    Paredes, Roger
    Sweeney, Daniel A.
    Short, William R.
    Touloumi, Giota
    Lye, David Chien
    Ohmagari, Norio
    Oh, Myoung-don
    Ruiz-Palacios, Guillermo M.
    Benfield, Thomas
    Faetkenheuer, Gerd
    Kortepeter, Mark G.
    Atmar, Robert L.
    Creech, C. Buddy
    Lundgren, Jens
    Babiker, Abdel G.
    Pett, Sarah
    Neaton, James D.
    Burgess, Timothy H.
    Bonnett, Tyler
    Green, Michelle
    Makowski, Mat
    Osinusi, Anu
    Nayak, Seema
    Lane, H. Clifford
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (19) : 1813 - 1826
  • [5] Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
    Bernal, A. Jayk
    da Silva, M. M. Gomes
    Musungaie, D. B.
    Kovalchuk, E.
    Gonzalez, A.
    Delos Reyes, V
    Martin-Quiros, A.
    Caraco, Y.
    Williams-Diaz, A.
    Brown, M. L.
    Du, J.
    Pedley, A.
    Assaid, C.
    Strizki, J.
    Grobler, J. A.
    Shamsuddin, H. H.
    Tipping, R.
    Wan, H.
    Paschke, A.
    Butterton, J. R.
    Johnson, M. G.
    De Anda, C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (06) : 509 - 520
  • [6] Challenges and Controversies to Testing for COVID-19
    Binnicker, Matthew J.
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (11)
  • [7] Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
    Bruel, Timothee
    Hadjadj, Jerome
    Maes, Piet
    Planas, Delphine
    Seve, Aymeric
    Staropoli, Isabelle
    Guivel-Benhassine, Florence
    Porrot, Francoise
    Bolland, William-Henry
    Nguyen, Yann
    Casadevall, Marion
    Charre, Caroline
    Pere, Helene
    Veyer, David
    Prot, Matthieu
    Baidaliuk, Artem
    Cuypers, Lize
    Planchais, Cyril
    Mouquet, Hugo
    Baele, Guy
    Mouthon, Luc
    Hocqueloux, Laurent
    Simon-Loriere, Etienne
    Andre, Emmanuel
    Terrier, Benjamin
    Prazuck, Thierry
    Schwartz, Olivier
    [J]. NATURE MEDICINE, 2022, 28 (06) : 1297 - +
  • [8] Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
    Choi, Bina
    Choudhary, Manish C.
    Regan, James
    Sparks, Jeffrey A.
    Padera, Robert F.
    Qiu, Xueting
    Solomon, Isaac H.
    Kuo, Hsiao-Hsuan
    Boucau, Julie
    Bowman, Kathryn
    Das Adhikari, U.
    Winkler, Marisa L.
    Mueller, Alisa A.
    Hsu, Tiffany Y. -T.
    Desjardins, Michael
    Baden, Lindsey R.
    Chan, Brian T.
    Walker, Bruce D.
    Lichterfeld, Mathias
    Brigl, Manfred
    Kwon, Douglas S.
    Kanjilal, Sanjat
    Richardson, Eugene T.
    Jonsson, A. Helena
    Alter, Galit
    Barczak, Amy K.
    Hanage, William P.
    Yu, Xu G.
    Gaiha, Gaurav D.
    Seaman, Michael S.
    Cernadas, Manuela
    Li, Jonathan Z.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (23) : 2291 - 2293
  • [9] Communicable Diseases Genomics Network, VAR CONC
  • [10] ESR (Institute of Environmental Science and Research), COVID 19 GEN INS DAS